In addition to multicenter consultation, the expression of immunohistochemical markers, such as estrogen receptor (ER), progesterone receptor (PR), p53, p16, and Ki67, is helpful for pathologists to differentiate leiomyosarcoma, leiomyoma, and STUMPs. This evidence concerns the gene PGR and leiomyoma.